Arcadia Biosciences, Inc. Annual Report: A Plain-English Summary

I’ve put together this guide to help you understand how Arcadia Biosciences performed this year. Instead of digging through dense financial filings, we’re breaking down what’s actually happening so you can decide if it fits your investment goals.

1. What does the company do?

Arcadia Biosciences is an agricultural technology company currently shifting its focus toward consumer-facing wellness products, specifically its Zola coconut water brand.

This year, Arcadia sold its "GoodWheat" business and wheat-related traits to Corteva Agriscience and Above Food Corp. for a combined $7.7 million. By selling these assets, Arcadia is moving away from its roots in wheat to simplify operations, reduce overhead, and focus entirely on its remaining consumer goods.

2. The Canceled Merger

Arcadia previously planned to merge with Roosevelt Resources in an "all-stock" deal. In December 2025, the parties terminated the agreement because they could not meet specific closing requirements, such as maintaining a minimum level of working capital. Arcadia remains independent, meaning they must now navigate a standalone future with their current resources.

3. Financial Performance

The company is in a significant transition. For the year ending December 31, 2025, revenue from continuing operations was approximately $5.2 million. This figure reflects the exclusion of the GoodWheat business, which is now classified as "discontinued."

The company reported a loss of approximately $8.4 million. While selling assets helped lower operating expenses, the cost of running the business continues to outpace the profit generated by Zola coconut water sales.

4. Financial Health

Arcadia is operating in a tight cash environment. As of March 2026, the company held about $3.1 million in cash. With a burn rate of $1 million to $1.5 million per quarter, their financial runway is limited.

Following a 1-for-40 reverse stock split in 2024, the company has about 2 million shares outstanding. For a company of this size, the low share count can lead to increased price volatility, as even minor changes in trading volume can cause significant moves in the stock price.

5. Key Risks

• Dilution: Because the company is currently losing money, they may need to sell new shares to raise cash. This would reduce your ownership percentage and the value of your existing shares.
• Customer Concentration: A large portion of revenue comes from a few retail distributors for Zola. If a major retailer stops selling the product, the company’s revenue would drop significantly.
• Strategic Uncertainty: With the merger canceled, the path forward relies entirely on management’s ability to reach a "break-even" point. Investors are currently waiting to see if the company can sustain operations without needing to raise additional capital.

6. Future Outlook

Management is focused on "right-sizing" the company by cutting non-core segments to lower overhead. The goal is to reach a point where they no longer lose cash, but they have yet to establish a proven, profitable path forward. The company’s future depends on growing Zola’s market share while keeping total costs below their $5 million annual revenue.

Investor Takeaway: Arcadia is currently a "show-me" story. They have moved away from their complex agricultural roots to focus on a single consumer brand, but their current cash burn and reliance on external funding remain the most important factors to watch. Before investing, consider whether you believe the Zola brand has the growth potential to cover the company's operating costs before their current cash reserves run out.